Latest Breaking News On - David miklos - Page 2 : comparemela.com

Medicine: Cell, gene therapies save lives, but can we afford them?

Medicine: Cell, gene therapies save lives, but can we afford them?
siliconvalley.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siliconvalley.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoAllison betof warnerGreg allenSarah emondStanford betof warnerDavid miklosGary goldsteinWendell limKendric cromerInstitute for clinicalGeorgetown university mccourt school of publicUc san francisco cell design instituteStanford blood marrow transplant programCell therapy programEconomic review

Breakthrough therapies are saving lives, but can we afford them?

Breakthrough therapies are saving lives, but can we afford them?
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoDavid miklosGary goldsteinKendric cromerStanford betof warnerWendell limGreg allenAllison betof warnerSarah emondGeorgetown university mccourt school of publicUc san francisco cell design instituteStanford blood marrow transplant programTribune content agencyCell therapy programInstitute for clinical

Medicine: Cell, gene therapies save lives, but can we afford them?

Medicine: Cell, gene therapies save lives, but can we afford them?
eastbaytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastbaytimes.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoGary goldsteinThomas orozcoKendric cromerDavid miklosSarah emondWendell limGreg allenStanford betof warnerAllison betof warnerStanford blood marrow transplant programStanford health careUc san francisco cell design instituteInstitute for clinicalStanford health carecell

Stanford Medicine delivers first FDA-approved cell-based therapy for solid tumors

Stanford Medicine delivers first FDA-approved cell-based therapy for solid tumors
stanford.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stanford.edu Daily Mail and Mail on Sunday newspapers.

United statesIovance biotherapeuticsKrista congerAllison betof warnerBetof warnerSteven rosenbergDavid miklosDrug administrationStanford school of medicineNational medal of technologyNational cancer instituteOffice of communicationsStanford medicineSan carlos based iovanceNational cancerNational medal

Kite Receives U S FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy

Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta® (axicabtagene ciloleucel). With this approval, Kite’s median turnaround time (TAT) in the U.S. is anticipated .

United statesStanford universityFoster citySanta monicaChris mcdonaldDavid miklosCindy perettieYescarta axicabtagene ciloleucelGilead companyGilead sciencesGilead company nasdaqExchange commissionCell therapy at stanford universityDrug administrationGilead sciences incKite authorized treatment centers